LFC0.F Lifecare ASA

Healthcare Medical Devices Frankfurt Exchange
0.0330 EUR
Close of Nov 12, 2026
0.0100 0.4900
Market cap
EUR 14.2M
P/E
-
P/B
2.65x
ROE
-114.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is LFC0.F undervalued?

Graham number

The Graham number of Lifecare ASA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lifecare ASA fundamental analysis

No fundamental analysis for Lifecare ASA yet.

Lifecare ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.

Full company profile